← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Addus grew revenue and earnings, but cash flow slipped as investment and SBC rose.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +23.2% to $1.42BOK
- Profitability — Net income +30.3% to $95.9MOK
- Cash quality — FCF -6.0% to $104MWatch
- Margins — Operating margin +85 bps; FCF margin -226 bpsNote
- Balance sheet — Debt -44.6%; equity +11.8%OK
- Insiders — 0 buys / 39 sellsWatch
- Accounting — Z safe; M-score clean; EQ safeOK
Business
Addus provides in-home personal care, hospice, and home health services, mainly under agreements with government agencies, managed care organizations, insurers, and private-pay consumers.
Where the revenue comes from
Fiscal 2025, as Addus HomeCare Corp reports it. History and quarterly detail are in the app.
- Personal Care$1.1B
- Hospice$262.5M
- Home Health$70.8M
Leadership changes
From Addus HomeCare Corp's own filings, the day they're filed.
- Future Retirement · Chief Operating Officer · departureeff. 2026-03-10
- W. Bradley Bickham · Chief Operating Officer · departureeff. 2026-03-10
- Heather Dixon · Chief Operating Officer · departure
Latest filings
- 8-K · Company announcement2026-08-13
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-08-03
- 8-K · Company announcement2026-06-10
- 10-Q · Quarterly report2026-05-05
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Addus HomeCare Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.